David, I also appreciated your comment that you've seen some federal leadership coming on this.
The Minister of Health has laid out a comprehensive five-point federal strategy, including better informing Canadians about the risks of opioids, supporting better prescription practices, reducing the access to unnecessary opioids, supporting better treatment options, and improving the gathering of evidence and getting the evidence together. The naloxone capability was made possible, and the nasal sprays are now coming in from the U.S.
I heard a number of recommendations from you and from Bonnie.
From Bonnie I heard about expanding supervised consumption services, and that Bill C-2 is a major problem across Canada; establishing drug checking as a harm reduction service to make sure you can see what you're ingesting, even if it's illegal; and increasing availability of treatments for opioid use disorders.
From David I heard about prescription changes and better education of physicians to make sure that the use of opioids is better managed.
All of you referenced better surveillance, and that we need a national surveillance program for this.
I heard from John that the dosage of naloxone needs to be increased in some of these kits.
Are there any other recommendations beyond these? The minister is convening a workshop in November as a special consultation. Is there any other advice you can give us to better the situation or to give advice to the minister?